Boaz Shenhav
Algemeen Directeur bij Hairstetics Ltd.
Profiel
Boaz Shenhav is the founder and CEO of Hairstetics Ltd.
which was founded in 2010.
He is currently the CEO of Bio Refine Ltd.
since 2019.
Mr. Shenhav holds a Master's in Business Administration from Cornell University and an undergraduate degree from Technion-Israel Institute of Technology.
Actieve functies van Boaz Shenhav
Bedrijven | Functie | Begin |
---|---|---|
Hairstetics Ltd.
Hairstetics Ltd. Medical SpecialtiesHealth Technology Hairstetics Ltd. engages in the development and manufacturing of hair restoration devices. The company was founded by Moshe Lapidoth, Ran Koronowski, Boaz Shenhav and Dvir Keren in 2010 and is headquartered in Omer, Israel. | Algemeen Directeur | 08-09-2011 |
Bio Refine Ltd.
Bio Refine Ltd. Medical SpecialtiesHealth Technology Bio Refine Ltd. develops endovascular annuloplasty remodeling systems. The company is based in Tel Aviv, Israel. The Israeli company was founded in 2019. Boaz Shenhav has been the CEO of the company since 2019. | Algemeen Directeur | 01-07-2019 |
Opleiding van Boaz Shenhav
Cornell University | Masters Business Admin |
Technion-Israel Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Hairstetics Ltd.
Hairstetics Ltd. Medical SpecialtiesHealth Technology Hairstetics Ltd. engages in the development and manufacturing of hair restoration devices. The company was founded by Moshe Lapidoth, Ran Koronowski, Boaz Shenhav and Dvir Keren in 2010 and is headquartered in Omer, Israel. | Health Technology |
Bio Refine Ltd.
Bio Refine Ltd. Medical SpecialtiesHealth Technology Bio Refine Ltd. develops endovascular annuloplasty remodeling systems. The company is based in Tel Aviv, Israel. The Israeli company was founded in 2019. Boaz Shenhav has been the CEO of the company since 2019. | Health Technology |